UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Volatile indices reflect rapid price changes, offering both risk and opportunity for traders who monitor momentum and volatility indicators.
12,196 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
If you’re hunting for a stock that could turn a $10,000 stake into a life-changing payout by 2030, you’re not alone. ...
Travel rewards can lose value in minutes if you move points without a locked-in stay. This report explains the risk a...
South Carolina passed a landmark bill banning central bank digital currencies and guaranteeing tax neutrality for dig...
New data shows single Gen Z women buying first homes at a higher rate than single Gen Z men, signaling a broader shif...
When a stock climbs 15% after a fund trims its position, investors should look beyond the headline. This article brea...
SpaceX’s S-1 filing puts Elon Musk’s Mars ambitions under the public lens, inviting investors to weigh a multi-billio...
cdl’s $2.29 annual dividend remains resilient as Treasuries climb, offering a steady monthly cash flow through a uniq...
Policy clarity cleared a Senate hurdle, but bitcoin demand weakens despite the CLARITY Act win as ETF buyers pull bac...
Jaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
Set up your weekend with a curated mix of Friday reads for investors. This guide rounds up 10 must-check pieces that ...